, 1 14 , 30 26 , 4.5 3.7 .
Clinical trials show average weight loss of 1015% over 68 weeks, though results vary
The peptide distributes widely across tissues, particularly those involved in repair processes, such as muscles, tendons, and the gastrointestinal tract
whereas HLA-DR averages were 32 12 % for MAHT 4mg, 27 12 % for MAHT 8mg, and 29 12 % for RI 10mg
Gastrointestinal tolerability of once?weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
Retrieved May 15, 2025, from Wang, J.-Y., et al